Stent thrombosis: who's guilty?

被引：17

作者：

Montalescot, Gilles ^{[1
]}

Hulot, Jean-Sebastien ^{[2
]}

Collet, Jean-Philippe ^{[1
]}

机构：

[1] Univ Paris 06, INSERM 937, Inst Cardiol, Hop Pitie Salpetriere,AP HP, F-75013 Paris, France

[2] Hop La Pitie Salpetriere, INSERM 956, AP HP, Serv Pharmacol,Unite Pharmacogenet, F-75013 Paris, France

来源：

EUROPEAN HEART JOURNAL | 2009年 / 30卷 / 22期

关键词：

DRUG-ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; BARE-METAL STENTS; OF-FUNCTION POLYMORPHISM; PLATELET REACTIVITY; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; CARE ASSAY; CLOPIDOGREL; PRASUGREL;

D O I：

10.1093/eurheartj/ehp436

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：2685 / 2688

页数：4

共 27 条

[1]

[Anonymous], 2009, J AM COLL CARDIOL

[2]

Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis [J].

Buonamici, Piergiovanni ;

Marcucci, Rossella ;

Migliorini, Angela ;

Gensini, Gian Franco ;

Santini, Alberto ;

Paruccia, Rita ;

Moschi, Guia ;

Gori, Anna Maria ;

Abbate, Rosanna ;

Antoniucci, David .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (24) :2312-2317

[3]

Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial [J].

Collet, Jean-Philippe ;

Montalescot, Gilles ;

Steg, Philippe Gabriel ;

Steinhubl, Steven R. ;

Fox, Keith A. A. ;

Hu, Ting Fei ;

Johnston, S. Claiborne ;

Hamm, Christian W. ;

Bhatt, Deepak L. ;

Topol, Eric J. .

ARCHIVES OF CARDIOVASCULAR DISEASES, 2009, 102 (6-7) :485-496

[4]

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study [J].

Collet, Jean-Philippe ;

Hulot, Jean-Sebastien ;

Pena, Anna ;

Villard, Eric ;

Esteve, Jean-Baptiste ;

Silvain, Johanne ;

Payot, Laurent ;

Brugier, Delphine ;

Cayla, Guillaume ;

Beygui, Farzin ;

Bensimon, Gilbert ;

Funck-Brentano, Christian ;

Montalescot, Gilles .

LANCET, 2009, 373 (9660) :309-317

[5]

Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes [J].

Collet, JP ;

Montalescot, G ;

Blanchet, B ;

Tanguy, ML ;

Golmard, JL ;

Choussat, R ;

Beygui, F ;

Payot, L ;

Vignolles, N ;

Metzger, JP ;

Thomas, D .

CIRCULATION, 2004, 110 (16) :2361-2367

[6]

EasyMA: A program for the meta-analysis of clinical trials [J].

Cucherat, M ;

Boissel, JP ;

Leizorovicz, A ;

Haugh, MC .

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1997, 53 (03) :187-190

[7]

Safety of Short-Term Discontinuation of Antiplatelet Therapy in Patients With Drug-Eluting Stents [J].

Eisenberg, Mark J. ;

Richard, Pierre R. ;

Libersan, Danielle ;

Filion, Kristian B. .

CIRCULATION, 2009, 119 (12) :1634-U129

[8]

Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis [J].

Giusti, Betti ;

Gori, Anna Maria ;

Marcucci, Rossella ;

Saracini, Claudia ;

Sestini, Ilaria ;

Paniccia, Rita ;

Buonamici, Piergiovanni ;

Antoniucci, David ;

Abbate, Rosanna ;

Gensini, Gian Franco .

AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (06) :806-811

[9]

GURBEL PA, 2009, J AM COLL CARDIOL S1, V10

[10]

Withdrawal of statins increases event rates in patients with acute coronary syndromes [J].

Heeschen, C ;

Hamm, CW ;

Laufs, U ;

Snapinn, S ;

Böhm, M ;

White, HD .

CIRCULATION, 2002, 105 (12) :1446-1452

← 1 2 3 →